Ewing sarcoma: Difference between revisions

(Created page with "==Background== *Highly aggressive malignant bone or soft tissue tumor arising from cells of the neuroectoderm *One-fourth of patients will have metastasis at the time of prese...")
 
Line 7: Line 7:
*Around 70 to 80 percent survival in those with non-metastatic disease
*Around 70 to 80 percent survival in those with non-metastatic disease
*More common in males
*More common in males


==Clinical Features==
==Clinical Features==

Revision as of 22:34, 21 November 2019

Background

  • Highly aggressive malignant bone or soft tissue tumor arising from cells of the neuroectoderm
  • One-fourth of patients will have metastasis at the time of presentation
    • It is assumed that almost all patients have subclinical metastasis
  • Presence and location of metastasis is the major prognostic factor for survival
  • Metastasis is most frequently seen in bone (spine most common) and lungs
  • Around 70 to 80 percent survival in those with non-metastatic disease
  • More common in males

Clinical Features

Differential Diagnosis

Evaluation

Management

Disposition

References